Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Annals of Translational Medicine|September 16, 2022
Model development to predict central lymph node metastasis in cN0 papillary thyroid microcarcinoma by machine learningYaocheng Yu, Zhiwei Yu, Mengxuan Li, et al.
Oncotarget|April 19, 2017
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibodyYing Chen, Fengtao You, Licui Jiang, et al.
European Journal of Medical Research|March 21, 2023
B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemiaShuangshuang Fan, Tian Wang, Fengtao You, et al.
Communications Biology|November 7, 2023
High-level production of nervonic acid in the oleaginous yeast Yarrowia lipolytica by systematic metabolic engineeringHang Su, Penghui Shi, Zhaoshuang Shen, et al.
The International Journal of Biochemistry & Cell Biology|April 26, 2012
The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migrationXingding Zhang, Yu Jing, Yang Qin, et al.
Heliyon|July 7, 2023
CD7 protein plays a crucial role in T cell infiltration in tumorsBinjie Sheng, Kailu Zhang, Shuaiyu Tian, et al.
Signal Transduction and Targeted Therapy|June 12, 2026
Anlotinib combined with neoadjuvant chemotherapy for HR+/HER2- breast cancer (ACNTBC): a prospective, single-arm, single-center phase II clinical study with real-world validationJiajun Ding, Huimin Meng, Yidi Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 27, 2022
Unexpected High-Performance Photocatalytic Hydrogen Evolution in Co@NCNT@ZnIn2 S4 Triggered by Directional Charge Separation and TransferMengxi Tan, Chao Huang, Chengye Yu, et al.
American Journal of Cancer Research|December 7, 2021
Chimeric antigen receptor T cells derived from CD7 nanobody exhibit robust antitumor potential against CD7-positive malignanciesDan Chen, Fengtao You, Shufen Xiang, et al.
American Journal of Cancer Research|February 1, 2021
MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activityXiaochen Zhai, Fengtao You, Shufen Xiang, et al.
Pageof 4